#Paid content sponsored by Intel.
In this video interview, I talk with David Chou, Vice President, Chief Information and Digital Officer with Kansas City, Missouri-based Children’s Mercy Hospital. In addition to his work at Children’s Mercy, he helps healthcare organizations transform themselves into digital enterprises.
Chou previously served as a healthcare technology advisor with law firm Balch & Bingham and Chief Information Officer with the University of Mississippi Medical Center. He also worked with the Cleveland Clinic to build a flagship hospital in Abu Dhabi, as well as working in for-profit healthcare organizations in California.
Precision Medicine and Genomic Medicine are important topics for every hospital CIO to understand. In my interview with David Chou, he provides the hospital CIO perspective on these topics and offers insights into what a hospital organization should be doing to take part in and be prepared for precision medicine and genomic medicine.
Here are the questions I asked him, if you’d like to skip to a specific topic in the video or check out the full video interview embedded below:
- What’s the CIO’s perspective on precision medicine and genomics?
- What do you need to do to prepare your organization for the shift to precision medicine?
- What are some examples of where precision medicine-based care is already a reality?
- Who should lead precision medicine efforts?
- Where do you think precision medicine is headed? What should CIOs expect to see happen ten or 20 years down the road?
- Are smaller healthcare players going to be able to participate in precision medicine and automation, or will they be shut out?
- Do you think precision care and genomic medicine are going to become the standard?
- What’s the most exciting thing you see happening in precision medicine, and how are you going to take advantage of it?
- What’s your approach to balancing on-premise storage and cloud storage?
- What would say to someone who thinks that talk of precision medicine is all hype?
What are you doing in your organization when it comes to precision medicine and genomic medicine?